Director Legorreta buys 22,617,909 shares of PROK for $54.7M; stock down 79.1% from 52-wk high, company unprofitable.
Legorreta Pablo G., a Director, purchased 22,617,909 shares for $54,735,339.78, establishing a new position after holding zero shares pre-transaction. The timing is notable: PROKIDNEY CORP trades at $2.73, down 79.1% from its 52-week high of $13.08, and the stock has fallen 30.4% over the past 30 days despite a 93.6% gain over 90 days. The company reported a net loss of $9,492,000 over its most recent full fiscal year, indicating ongoing operating challenges. Legorreta's historical cross-ticker insider trading record shows 6 prior buys with a 0.00% 90-day win rate and an average 90-day return of -10.1%, suggesting his open-market purchases have not preceded price appreciation. This substantial new commitment by a director into a loss-making company at a deeply depressed valuation demands scrutiny regarding his motivation and information access.